Current Affairs - International - Discussion

The World Health Organisation (WHO) approved the first molecular diagnostic test for the Bundibugyo Ebola virus under its Emergency Use Listing (EUL) on July 2, 2026, to strengthen outbreak response efforts in Africa. The test detects the virus's genetic material directly from blood samples, allowing faster and more accurate diagnosis. It is specifically designed for the Bundibugyo strain, which is different from the Zaire strain and requires separate diagnostic tools. The approval supports timely detection, better disease surveillance, and improved public health measures, particularly in the Democratic Republic of the Congo, where the outbreak is ongoing.